ABSTRACT
Objective:To explore the effect of regular aerobic exercise on oxidative stress, inflammatory reaction and apoptosis with a rat model of colitis.Methods:Forty-five C57BL/6 mice were randomly divided into a control group, a model group and a model exercise group, each of 15. Colitis was induced in the rats of the model and model exercise groups through administration of 3.5% sodium dextran sulfate. The control group and the model group were kept quiet in their cages, while the model exercise group performed voluntary wheel running for 8 weeks after the successful modelling. Any histopathological changes in the colon tissue were observed after hematoxylin and eosin staining. Oxidative stress, inflammatory reaction and apoptosis were measured from colon tissue homogenates.Results:Compared with the control group, the average expression of the tumor necrosis factor α (TNF-α), interleukin (IL)-1β, IL-6 and prostaglandin E2 (PGE2) as well as levels of reactive oxygen species (ROS), malondialdehyde (MDA) and nitric oxide (NO) and inducible nitric oxide synthase (iNOS) and Caspase-3 activity and the protein expression of cyclooxygenase 2 (COX2), nuclear factor kappa B (NF-κB) p65, apoptosis inducing factor (AIF), cytochrome c (Cyt C) and Bax had all increased significantly in the other two groups, while the levels of IL-10 and glutathione (GSH), the activity of superoxide dismutase (SOD) and glutathione peroxidase (GPx) and the protein expression of Bcl-2 protein had decreased significantly in the model group. Compared with the model group, the average content of TNF-α, IL-1 β, IL-6, PGE2, ROS, MDA and NO, the activity of iNOS and Caspase-3 and the protein expression of COX2, NF-κB p65, AIF, CytC and Bax had decreased significantly, while that of IL-10 and GSH, the activity of SOD and GPx and the protein expression of Bcl-2 protein had increased significantly in the model exercise group.Conclusion:Regular aerobic exercise has a protective effect against colitis through improving oxidative stress, inflammation and apoptosis, at least in rats.
ABSTRACT
Objective:To observe the effect of hyaluronidase injection into tendon sheath under muscle bone ultrasound guidance in the treatment of tenosynovitis of long head of biceps brachii.Methods:134 patients with tenosynovitis of the long head of biceps brachii treated in SSL Central Hospital of Dongguan from April 2019 to April 2020 were selected as the research objects. All patients were randomly divided into ordinary injection group and ultrasound-assisted injection group, 67 cases in each group. The general injection group was treated with intra-articular injection of hyaluronidase, and the ultrasound-assisted injection group was treated with intra-tendon sheath injection of hyaluronidase under the guidance of muscle and bone ultrasound. Visual Analog Scales (VAS) score, active flexion joint motion (AFROM), shoulder range of motion (ROM), functional score, flexion strength score, nuclear magnetic resonance imaging (MRI) and local tenosynovitis of the long head of biceps brachii (TLHBB)were measured to evaluate the clinical effect and postoperative complications after treatment.Results:There was no significant difference in gender, age, course of disease, periarthritis of shoulder and disuse atrophy of muscles around shoulder between ordinary injection group and ultrasound-assisted injection group ( P>0.05). After treatment, the AFROM, ROM, function score, forward flexion strength score, and middle wedge angle (MWA) of the two groups were significantly higher than those before treatment ( P<0.05), while the VAS score, humeral head diameter (HHD), biceps long head tendon diameter (BTD), and TLBBB were significantly lower than those before treatment ( P<0.05). The AFROM, ROM, function score, and forward flexion strength score, MWA of the ultrasound-assisted injection group were significantly higher than those of the ordinary injection group ( P<0.05), and the VAS score, HHD, BTD, and TLHBB were significantly lower than those of the ordinary injection group ( P<0.05). The total effective rate of the ultrasound-assisted injection group was higher than that of the ordinary injection group (97.01% vs 85.07%, P<0.05). Conclusions:Intra-tendon sheath hyaluronidase injection guided by ultrasound can effectively treat tenosynouitis of the long head of biceps brachii, relieve shoulder pain and improve shoulder motion.
ABSTRACT
OBJECTIVE:To evaluate the efficacy and safety of semaglutide in the treatment of type 2 diabetes mellitus,and to provide evidence-based reference in clinic. METHODS:Retrieved from Wangfang,CNKI,PubMed,Embase,Medline and the Cochrane library,randomized controlled trials(RCTs)about semaglutide alone or combined with other hypoglycemic drugs(trial group)versus placebo or other hypoglycemic medicine alone or combination(control group)in the treatment of type 2 diabetes mellitus were collected. After data extraction and literature quality evaluation,Meta-analysis was performed by using Rev Man 5.3 software. RESULTS:Totally 7 literatures were included,involving 7 708 patients. Results of Meta-analysis showed that compared with control group,the level of glycosylated hemoglobin [vs. placebo:MD＝－1.48,95%CI(－1.68,－1.28),P＜0.001;vs. positive control medicine:MD＝－0.95,95%CI(－1.17,－0.73),P＜0.001],fasting plasma glucose [vs. placebo:MD＝－1.87, 95%CI(－2.25,－1.50),P＜0.001;vs. positive control medicine:MD＝－1.07,95%CI(－1.58,－0.55),P＜0.001],body weight [vs. placebo:MD＝－3.15,95%CI(－3.98,－2.32),P＜0.001;vs. positive control medicine:MD＝－3.64,95%CI (－4.60,－2.69),P＜0.001] and body weight index [vs. placebo:MD＝－1.11,95%CI(－1.40,－0.81),P＜0.001;vs. positive control medicine:MD＝－1.34,95%CI(－1.67,－1.00),P＜0.001] in trial group were decreased significantly. For safety,the incidence of nausea and diarrhea of somaglutide was significantly higher than control group(P＜0.05). CONCLUSIONS:Semaglutide showes superiority in reducing the levels of glycosylated hemoglobin,fasting plasma glucose,body weight and body weight index in patients with type 2 diabetes mellitus,but the occurrence of nausea and diarrhea in patient should be monitored.
ABSTRACT
<p><b>OBJECTIVE</b>To compare the differences in the clinical therapeutic effects on reflux esophagitis among the combined therapy ofdecoction (the decoction for resolving the turbid, detoxification and reducing the pathologic upwardin short) and acupuncture, omeprazole and Chinese herbal medicine.</p><p><b>METHODS</b>Ninety patients were randomized into 3 groups, 4 cases of them were dropped off. Finally, there were 29 cases in the combined therapy group with acupuncture and the decoction, 29 cases in the western medication group and 28 cases in the Chinese herbal medicine group in the statistical analysis. In the combined therapy group with acupuncture and the decoction, the decoction was prescribed recurrence rate. The therapeutic effects are better than the simple application of either Chinese herbal medicine or omeprazole. for oral administration. Additionally, acupuncture was applied to Neiguan (PC 6), Zusanli (ST 36), Zhongwan (CV 12), Ganshu (BL 18), Danshu (BL 19) and Taichong (LR 3). The decoction was applied one dose a day and acupuncture was once a day. In the western medication group, omeprazole capsules, 20 mg were prescribed for oral administration, twice a day. In the Chinese herbal medicine group, the decoction was simply applied. The treatment was 8 weeks in the 3 groups and the follow-up visit was 6 months. The score of reflux disorder questionnaire (RDQ) and the changes in esophageal mucosa under gastroscope were observed before and after treatment; the clinical therapeutic effects and recurrence rate were evaluated in the 3 groups.</p><p><b>RESULTS</b>In 4 and 8 weeks of treatment, RDQ scores in the 3 groups were all reduced as compared with those before treatment (all<0.05). In 4 weeks of treatment, RDQ score in the combined therapy group with acupuncture and Chinese herbal medicine was lower than that in the western medication group (<0.05). In 8 weeks of treatment, RDQ score in the combined therapy group with acupuncture and Chinese herbal medicine was lower than those in the western medication group and the Chinese herbal medicine group (both<0.05). In follow-up visit for 6 months, the recurrence rate in the combined therapy group with acupuncture and the decoction was lower than those in the other two groups (both<0.05). In 8 weeks of treatment, the total effective rate for clinical symptoms and that observed under gastroscope in the combined therapy group with acupuncture and the decoction were all better than those in the western medication group and the Chinese herbal medicine group (all<0.05).</p><p><b>CONCLUSIONS</b>The combined therapy ofdecoction and acupuncture achieve the definite therapeutic effects on reflux esophagitis, relieve the symptoms, protect gastric mucosa and reduce the.</p>
ABSTRACT
[Objective] To observe the therapeutic effect of diarrhea-predominant irritable bowel syndrome patients’ life quality with Geshanxiaoyao decoction combining acupuncture.[Methods] 300 patients were randomly divided into therapeutic group (n=150) and control 1,2,3 groups (n=50).150 cases were treated with Geshanxiaoyao decoction combined with pricking taichong,sanyinjiao,shaohai; control 1,2,3 groups were respectively treated with Li-Zhu-Chang-Le,Geshanxiaoyao decoction and acupuncture,4 weeks a course.Clinical symptoms and life quality before and after treatment were recorded and analyzed.[Results] The total effective ratio in therapeutic group(89.71%) was higher than that in control 1,2,3 groups (68.52%,74.31%,66.87%) respectively.There was significant difference between therapeutic group and control groups.[Conclusion]Geshanxiaoyao decoction combining acupuncture can effectively improve the life quality of patients with diarrhea-predominant irritable bowel syndrome.